Emerging drugs for the treatment of acne. (March 2015)
- Record Type:
- Journal Article
- Title:
- Emerging drugs for the treatment of acne. (March 2015)
- Main Title:
- Emerging drugs for the treatment of acne
- Authors:
- Aslam, Imran
Fleischer, Alan
Feldman, Steve - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold> <italic>Introduction</italic> </bold>: Acne is the most common skin condition in the US. The mainstay of acne therapy includes: topical retinoids, topical antibiotics, benzoyl peroxide (BP), and oral isotretinoin for severe cases. Although these treatment options are highly effective they do have certain drawbacks. Current acne treatment regimens often require patients to use multiple medications, some of which may have irritating side effects. Furthermore, <italic>Propionibacterium acnes</italic> resistance to antibiotics has become an increasing problem due to the rise in antibiotic use.</p> <p> <bold> <italic>Areas covered</italic> </bold>: New therapies that have either been released onto the market or that are being developed include: adapalene-BP combination agent, dapsone 5% gel, minocycline foam, topical nitric oxide-releasing agent, cortexolone 17 α-propionate, and CIP isotretinoin. Some of these new therapies address the challenges faced with existing treatment options. For instance, the relatively new combination therapy, adapalene-BP, limits antibiotic resistance and also helps simplify treatment regimens. The newly developed topical nitric oxide-releasing agent also holds potential in limiting antibiotic resistance.</p> <p> <bold> <italic>Expert opinion</italic> </bold>: Many of the new therapies discussed in this paper are still in early stages of testing so it is difficult to predict<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold> <italic>Introduction</italic> </bold>: Acne is the most common skin condition in the US. The mainstay of acne therapy includes: topical retinoids, topical antibiotics, benzoyl peroxide (BP), and oral isotretinoin for severe cases. Although these treatment options are highly effective they do have certain drawbacks. Current acne treatment regimens often require patients to use multiple medications, some of which may have irritating side effects. Furthermore, <italic>Propionibacterium acnes</italic> resistance to antibiotics has become an increasing problem due to the rise in antibiotic use.</p> <p> <bold> <italic>Areas covered</italic> </bold>: New therapies that have either been released onto the market or that are being developed include: adapalene-BP combination agent, dapsone 5% gel, minocycline foam, topical nitric oxide-releasing agent, cortexolone 17 α-propionate, and CIP isotretinoin. Some of these new therapies address the challenges faced with existing treatment options. For instance, the relatively new combination therapy, adapalene-BP, limits antibiotic resistance and also helps simplify treatment regimens. The newly developed topical nitric oxide-releasing agent also holds potential in limiting antibiotic resistance.</p> <p> <bold> <italic>Expert opinion</italic> </bold>: Many of the new therapies discussed in this paper are still in early stages of testing so it is difficult to predict their outlook; however, based on preliminary findings, these therapies seem to be promising.</p> </abstract> … (more)
- Is Part Of:
- Expert opinion on emerging drugs. Volume 20:Number 1(2015:Mar.)
- Journal:
- Expert opinion on emerging drugs
- Issue:
- Volume 20:Number 1(2015:Mar.)
- Issue Display:
- Volume 20, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 20
- Issue:
- 1
- Issue Sort Value:
- 2015-0020-0001-0000
- Page Start:
- 91
- Page End:
- 101
- Publication Date:
- 2015-03
- Subjects:
- Drugs -- Research -- Handbooks, manuals, etc
Drugs -- Design -- Periodicals
615.1072 - Journal URLs:
- http://informahealthcare.com/journal/emd ↗
http://informahealthcare.com ↗
http://iris.ashley-pub.com/vl=930529/cl=16/nw=1/rpsv/journal/journal4_home.htm ↗ - DOI:
- 10.1517/14728214.2015.990373 ↗
- Languages:
- English
- ISSNs:
- 1472-8214
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002950
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3360.xml